Wnt-10b Activators
Wnt-10b Activators constitute a specialized category of chemical compounds designed to modulate the activity of the Wnt-10b protein, a member of the Wnt family of secreted glycoproteins. The Wnt signaling pathway is a highly conserved and intricate signaling cascade that plays pivotal roles in embryonic development, tissue homeostasis, and cell differentiation. Wnt-10b, in particular, is known for its involvement in various biological processes, including osteogenesis, adipogenesis, and tissue regeneration. It functions by binding to cell surface receptors and initiating a cascade of intracellular events that ultimately regulate gene expression, influencing cellular behavior and fate.
Wnt-10b Activators are compounds engineered to interact with Wnt-10b and modify its signaling activity. These activators can either enhance or inhibit the effects of Wnt-10b, depending on their chemical structure and mode of action. By targeting Wnt-10b, these compounds offer researchers a means to investigate the intricate mechanisms of Wnt signaling and the specific functions of Wnt-10b in various cellular contexts. The study of Wnt-10b Activators is instrumental in advancing our understanding of how Wnt signaling governs tissue development, regeneration, and maintenance, as well as how perturbations in this pathway can contribute to developmental disorders and diseases. Researchers continue to explore the precise mechanisms of Wnt-10b activation and its implications in cellular physiology, providing valuable insights into the complex network of signaling pathways that orchestrate essential biological processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
GSK-3 Inhibitor IX stabilizes β-catenin, leading to enhanced Wnt signaling and indirect activation of Wnt-10b. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
GSK-3 Inhibitor XVI promotes β-catenin stabilization and Wnt signaling enhancement, indirectly activating Wnt-10b. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
LiCl inhibits GSK-3β, leading to the accumulation of β-catenin and indirect activation of Wnt-10b signaling. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
IWP-2 inhibits Wnt production and release by blocking Porcupine, leading to a compensatory increase in Wnt 10b activity as a homeostatic response. | ||||||
IWR-1-endo | 1127442-82-3 | sc-295215 sc-295215A | 5 mg 10 mg | $82.00 $135.00 | 19 | |
IWR-1 stabilizes Axin and promotes β-catenin degradation; however, this can lead to feedback activation of Wnt 10b signaling pathways as a compensatory mechanism. | ||||||
Wnt Synergist, QS11 | 944328-88-5 | sc-222417 sc-222417A | 5 mg 25 mg | $141.00 $607.00 | ||
QS11 acts as an activator of ARFGAP1, influencing Wnt/β-catenin signaling and indirectly activating Wnt-10b. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $202.00 $811.00 | 16 | |
SKL2001 activates Wnt/β-catenin signaling by disrupting the Axin-β-catenin interaction, indirectly upregulating Wnt 10b signaling. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB216763 is a GSK-3β inhibitor, leading to β-catenin stabilization and indirect activation of Wnt-10b. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid, a histone deacetylase inhibitor, can upregulate Wnt signaling genes, indirectly enhancing Wnt 10b activity through epigenetic modulation. | ||||||
β-Catenin/Tcf Inhibitor, FH535 | 108409-83-2 | sc-221398 sc-221398A | 10 mg 50 mg | $182.00 $374.00 | 7 | |
FH535, by inhibiting both Wnt/β-catenin and PPAR signaling, leads to a compensatory increase in Wnt 10b signaling to maintain cellular homeostasis. | ||||||